RxRevu – the Industry Leader in Prescription Decision Support – Secures $15.9 Million in Series A Funding Led by UCHealth

DENVER, June 4, 2019 /PRNewswire/ — RxRevu, the industry leader in Prescription Decision Support, has closed its Series A funding round with total proceeds of $15.9 million. The round was led by Colorado-based nonprofit health system, UCHealth. Additional investors include University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investors.

Through its SwiftRx® platform and underlying suite of Prescription Decision Support tools, RxRevu’s EHR-integrated technology allows healthcare professionals to make more informed prescribing decisions by considering everything from a patient’s medical history and individual insurance coverage to the out of pocket cost that patients will pay today at their favorite pharmacy.

“Our SwiftRx suite of tools makes it easier for clinicians to identify the right medicine for every patient. We provide both Real Time Benefit Check (RTBC) information and therapeutic alternatives to allow clinicians to see if there are less expensive options or options that do not require a prior authorization,” said Carm Huntress, co-founder and CEO of RxRevu. “One of our goals is to eliminate the millions of pharmacy call-backs because the patient is surprised at the cost of their medication, or that it is not covered under their plan, which leads to unfilled prescriptions and higher costs for everyone.”

The SwiftRx development effort required an ongoing collaboration between RxRevu and a leading innovative health system like UCHealth.

“UCHealth and our CARE Innovation Center have been working closely with RxRevu for more than two years in a co-development partnership. We share their vision to improve prescribing to help reduce medication costs and ensure our patients fill prescriptions with as little friction as possible,” said Richard Zane, M.D., chief innovation officer at UCHealth. “SwiftRx holds the promise to improve both our clinician and patient satisfaction. Finally, we will have an enterprise approach to better measure and manage our prescribing. We are excited by what is possible using this clinical decision support technology across our system.”

As health systems take on added pharmacy risk, manage increasingly complex data sets like pharmacogenomics, and adapt to new regulatory mandates for cost transparency, an enterprise approach to effective prescribing will be required.

“As a physician, former healthcare executive and current RxRevu board member, I see the issues facing healthcare today from every angle,” said Toby Cosgrove, M.D., executive advisor at Cleveland Clinic. “Like many things in healthcare, prescribing medicine has become very complex. New data sources combined with decision support tools like RxRevu’s SwiftRx will enable providers to incorporate the latest treatment standards, national guidelines and patient cost into one simple provider-centered workflow, so they can focus on the patient.”

Dr. Zane and Dr. Cosgrove have joined the RxRevu Board of Directors.

RxRevu invites any health system leaders interested in better prescribing at lower cost to contact us.

About RxRevu
RxRevu is a Denver-based company on a mission to improve healthcare through more informed, consistent and frictionless prescription decisions. RxRevu’s Prescription Decision Support technology promotes condition-appropriate prescribing and patient cost transparency, to improve safety and satisfaction. The SwiftRx® platform helps clinicians quickly and easily find affordable alternatives to more costly medications specific to a patient’s health needs and out of pocket cost. It also enables health systems to holistically manage and measure clinicians prescribing performance. For more information about RxRevu, its solutions and innovative advancements visit rxrevu.com.

About UCHealth
UCHealth is an innovative, nonprofit health system that delivers the highest quality medical care with an excellent patient experience. UCHealth combines Longs Peak Hospital, Yampa Valley Medical Center, Memorial Hospital Central, Memorial Hospital North, Poudre Valley Hospital, Medical Center of the Rockies, UCHealth Medical Group, Broomfield Hospital, Grandview Hospital, Pikes Peak Regional Hospital and University of Colorado Hospital into an organization dedicated to health and providing unmatched patient care in the Rocky Mountain West. With more than 150 clinic locations, UCHealth pushes the boundaries of medicine, providing advanced treatments and clinical trials and improving health through innovation.

View original content to download multimedia:http://www.prnewswire.com/news-releases/rxrevu–the-industry-leader-in-prescription-decision-support–secures-15-9-million-in-series-a-funding-led-by-uchealth-300861028.html

SOURCE RxRevu

Staff

Recent Posts

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN…

2 days ago

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB)…

2 days ago

Lowell Farms Inc. Announces Change of Chief Financial Officer

SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL;…

2 days ago

PetVivo Reports Reports Fiscal 2024 Results

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW),…

2 days ago

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…

2 days ago

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a…

2 days ago